In light of claims of improved efficacy and lower incidence of adverse effects compared with older drugs ... and the current classification scheme for antipsychotics does not survive close ...

In addition to antipsychotics, other medications used include lithium, thyroid hormone, low doses of stimulants, anticonvulsants, and other classes of antidepressants, such as tricyclic ...

To overcome such a serious mental disorder, we currently have a number of different classes of antidepressants ... Recently, second-generation antipsychotics (SGAs), olanzapine plus fluoxetine ...

“Cobenfy, we believe, will usher in a new class of medicine and will ... for launching the company’s last major drug to treat schizophrenia, the antipsychotic Abilify, in 2002.

An antipsychotic drug caused a teenager to develop the rare condition which led to his death, an inquest has heard. Oliver McGowan, 18, from Emerson's Green near Bristol was mildly autistic and ...

"is sometimes prescribed when people do not respond adequately to other antipsychotic medications. However, it may cause additional side effects, such as kidney or bladder problems," according to ...

Amitriptyline and maprotiline were the drugs most commonly implicated in these cases. Typical antipsychotics are recognized as having a greater risk of Q-Tc interval prolongation than are atypical ...

On 26 September 2024, Cobenfy (KarXT) gained US Food and Drug Administration (FDA) approval as the first novel class of antipsychotics in decades. Developed by Karuna Therapeutics, recently ...